148 related articles for article (PubMed ID: 29751345)
1. Facile fabrication of bowl-shaped microparticles for oral curcumin delivery to ulcerative colitis tissue.
Chen Q; Gou S; Huang Y; Zhou X; Li Q; Han MK; Kang Y; Xiao B
Colloids Surf B Biointerfaces; 2018 Sep; 169():92-98. PubMed ID: 29751345
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
Xiao B; Si X; Zhang M; Merlin D
Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840
[TBL] [Abstract][Full Text] [Related]
3. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles.
Ma P; Si X; Chen Q; Ma L; Hou M; Xu Z; Kang Y; Wang J; Xiao B
Curr Cancer Drug Targets; 2019; 19(4):304-311. PubMed ID: 30332962
[TBL] [Abstract][Full Text] [Related]
4. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues.
Huang Y; Canup BSB; Gou S; Chen N; Dai F; Xiao B; Li C
J Mater Chem B; 2021 Feb; 9(6):1604-1615. PubMed ID: 33471012
[TBL] [Abstract][Full Text] [Related]
5. Porous Polymeric Microparticles as an Oral Drug Platform for Effective Ulcerative Colitis Treatment.
Zhou X; Chen Q; Ma Y; Huang Y; Gou S; Xiao B
J Pharm Sci; 2019 Jul; 108(7):2238-2242. PubMed ID: 30779888
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy.
Chen Q; Gou S; Ma P; Song H; Zhou X; Huang Y; Kwon Han M; Wan Y; Kang Y; Xiao B
Int J Pharm; 2019 Feb; 557():135-144. PubMed ID: 30594685
[TBL] [Abstract][Full Text] [Related]
7. Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin.
Hou Y; Wang H; Zhang F; Sun F; Xin M; Li M; Li J; Wu X
Int J Nanomedicine; 2019; 14():557-571. PubMed ID: 30666114
[TBL] [Abstract][Full Text] [Related]
8. pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model.
Gugulothu D; Kulkarni A; Patravale V; Dandekar P
J Pharm Sci; 2014 Feb; 103(2):687-96. PubMed ID: 24375287
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery.
Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B
Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992
[TBL] [Abstract][Full Text] [Related]
10. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics.
Zhou X; Liu Y; Wang X; Li X; Xiao B
Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717
[TBL] [Abstract][Full Text] [Related]
11. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
[TBL] [Abstract][Full Text] [Related]
12. Enhancing stability and anti-inflammatory properties of curcumin in ulcerative colitis therapy using liposomes mediated colon-specific drug delivery system.
Wang C; Han Z; Wu Y; Lu X; Tang X; Xiao J; Li N
Food Chem Toxicol; 2021 May; 151():112123. PubMed ID: 33744379
[TBL] [Abstract][Full Text] [Related]
13. Curcumin-piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy.
Li Q; Zhai W; Jiang Q; Huang R; Liu L; Dai J; Gong W; Du S; Wu Q
Int J Pharm; 2015 Jul; 490(1-2):22-31. PubMed ID: 25957703
[TBL] [Abstract][Full Text] [Related]
14. Combined delivery of curcumin and the heme oxygenase-1 gene using cholesterol-conjugated polyamidoamine for anti-inflammatory therapy in acute lung injury.
Kim G; Piao C; Oh J; Lee M
Phytomedicine; 2019 Mar; 56():165-174. PubMed ID: 30668337
[TBL] [Abstract][Full Text] [Related]
15. An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice.
Li S; Jin M; Wu Y; Jung S; Li D; He N; Lee MS
Drug Deliv; 2021 Dec; 28(1):1120-1131. PubMed ID: 34121560
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of curcumin attenuates visceral hyperalgesia through inhibiting phosphorylation of TRPV1 in rat model of ulcerative colitis.
Yang M; Wang J; Yang C; Han H; Rong W; Zhang G
Mol Pain; 2017; 13():1744806917726416. PubMed ID: 28812431
[TBL] [Abstract][Full Text] [Related]
17. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
18. Colon-Targeted Oral Delivery of Hydroxyethyl Starch-Curcumin Microcapsules Loaded with Multiple Drugs Alleviates DSS-Induced Ulcerative Colitis in Mice.
Huang D; Zou M; Xu C; Wang Y; Xu Z; Zhang W; Tang S; Weng Z
Macromol Biosci; 2024 Apr; 24(4):e2300465. PubMed ID: 38111343
[TBL] [Abstract][Full Text] [Related]
19. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.
Yadav VR; Suresh S; Devi K; Yadav S
J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903
[TBL] [Abstract][Full Text] [Related]
20. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
Sareen R; Jain N; Rajkumari A; Dhar KL
Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
